There was a higher percentage of aggressive cancers such as TNBC and HER2 + BC in Q1 quintile compared to Q5 quintile (14.5%, 17.7% vs. 11.7%, 16.5% respectively, p < 0.001). Here, ERBB2 is linked to breast cancer.